Chemical Compound
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one; CRA 032765; Ibrutinib; Imbruvica; JNJ 02; PCI 32765; PCI 32765-00
CAS Registry Number
936563-96-1
Primary record
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one; CRA 032765; Ibrutinib; Imbruvica; JNJ 02; PCI 32765; PCI 32765-00
- 库存
- 7,806 克
- 纯度
- 98.3 %
- CAS
- 936563-96-1
化合物标识与属性
- CAS
- 936563-96-1
- PubChem CID
- 24821094
- SMILES
- C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
- Canonical SMILES
- C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
名称与同义词
- Ibrutinib
- 936563-96-1
- IMBRUVICA
- PCI-32765
- ibrutinibum
- Ibrutinib (PCI-32765)
- Ibrutinib [USAN]
- Imbruvica (TN)
- PCI 32765
- Ibrutinib (Standard)
- Ibrutinib, Free Base
- Ibrutinib [USAN:INN]
- PCI-32765 (Ibrutinib)
- 1X70OSD4VX
- IBRUTINIB [INN]
- IBRUTINIB [JAN]
- RefChem:57737
- UNII-1X70OSD4VX
- IBRUTINIB [MI]
- Ibrutinib (JAN/USAN)
- Ibrutinib Intermediate 2
- PCI32765
- IBRUTINIB [VANDF]
- CRA-032765
- C25H24N6O2
- Ibrutinib/PCI-32765
- Pc-32765
- D09KTS
- Ibrutinib (BTK inhibitor)
- IBRUTINIB [WHO-DD]
- Ibrutinib (PCI32765)
- Ibrutinib(PCI-32765)
- Imbruvica; PCI-32765
- JNJ 02
- PCI-32765(Ibrutinib)
- MFCD20261150
- CHEBI:76612
- MLS006010041
- SCHEMBL201859
- BTK Inhibitor PCI-32765
- DTXSID60893450
- Ibrutinib - Bio-X trade mark
- GTPL6912
- orb1307353
- PCI-32765 (Ibrutinib)?
- IBRUTINIB [ORANGE BOOK]
- CHEMBL1873475
- PCI-32765-00
- HSDB 8260
- EX-A066
- L01XE27
- XYFPWWZEPKGCCK-GOSISDBHSA-N
- DTXCID601323465
- GLXC-90098
- CRA 032765
- AMX10219
- AMY27873
- AOB87789
- KS-000002KE
- ABP000965
- BBF-05894
- BDBM50357312
- EBC-11432
- HY-10997R
- NSC800769
- ZINC35328014
- AKOS022185476
- C25-H24-N6-O2
- (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- ACN-030256
- AN-1333
- CS-0015
- DB09053
- EBD2165770
- EX-5960
- FA34130
- NSC-800769
- QC-4573
- NCGC00187912-01
- NCGC00187912-02
- NCGC00187912-03
- NCGC00187912-12
- NCGC00187912-17
- NCGC00187912-18
- AC-26942
- AJ-91306
- BI164531
- BP-43643
- CID:24821094
- HY-10997
- SC-96633
- SMR004701213
- SID:163679284
- AB0008168
- A3001
- NS00072153
- SW218096-2
- X7513
- EN300-97039
- J2.980.554G
- A11020
- D10223
- S-7810
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- A852882
- C551803
- F799864
- A1-01649
- Q5984881
- BRD-K70301465-001-02-6
- BRD-K70301465-001-05-9
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
- 1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one
- 2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-
- Z1302446275
- 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one.
- 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1- yl)prop-2-en-1-one
- 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]prop-2-en-1-one
- (R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-ylprop-2-en-1-one
- 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4 d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one; CRA 032765; Ibrutinib; Imbruvica; JNJ 02; PCI 32765; PCI 32765-00
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-2-propen-1-one
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine-1-yl]piperidino]-2-propene-1-one
- 1-[3alpha-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine-1-yl]piperidine-1-yl]-2-propene-1-one
- 1-{(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1- yl}prop-2-en-1-one
- 1E8
- 2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-
- 805-642-2